glp-1 dangers Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology A network meta-analysis backed weight-loss

[PubMed ID: 25268763]

J Obes 2024;2024:8056440.PubMedPMC REFERENCES PubReader ePub Link Cite this Article Cite this Article Close Download Citation Close XML Download Figure Fig

Poor pregnancy outcome for women with Type 2 diabetes

First, the poly-agonist thesis has achieved sufficient validation that the competitive question is no longer whether multi-receptor approaches will succeed, but rather which specific receptor combinations and ratios will prove optimal for different patient populations

Lancet 373, 21252135

Starting retatrutide at full maintenance doses after being on high-dose tirzepatide can lead to excessive GI side effects because of the additional glucagon receptor stimulation